The Biomarkers Consortium’s Cancer, Inflammation & Immunity, Metabolic Disorders and Neuroscience Steering Committees are responsible for identifying and moving forward promising pre-competitive biomarkers projects for implementation by The Biomarkers Consortium, as well as overseeing each individual project under its purview.

The members of each Steering Committee represent a variety of sectors, including academia, government, industry and not-for-profit/advocacy organizations, and are led by two co-chairs representing two of the following three sectors: academia, government or industry.

See below for the membership of each Biomarkers Consortium Steering Committee:

  Cancer Steering Committee

Gary Kelloff, M.D., NIH/NCI, (Co-Chair)
Eric Rubin, M.D., Merck (Co-Chair)
Lukas Amler, Ph.D., Genentech, a member of the Roche Group
Daniel Auclair, Ph.D., The Multiple Myeloma Research Foundation
J. Carl Barrett, M.D., AstraZeneca
Michelle Berny-Lang, Ph.D., NIH/NCI
Donald A. Berry, Ph.D., MD Anderson Cancer Center
Anahita Bhathena, Ph.D., AbbVie
Gideon Blumenthal, M.D., FDA/CDER
Lisa Butterfield, Ph.D., Society for Immunotherapy of Cancer
Claudio Carini, M.D., Ph.D., Oxford Biodynamics
Steven Cole, NIH/NCI
Ajeeta Dash, Ph.D., Takeda Pharmaceuticals International, Inc.
Phillip Dennis, M.D., Ph.D., AstraZeneca
Emmanuelle DiTomaso, Ph.D., Bayer
Michelle Douglas, Ph.D., Genentech, a member of the Roche Group
Gregory Friberg, M.D., Amgen
Ida Grundberg, Ph.D., Olink Proteomics
Stanley R. Hamilton, M.D., MD Anderson Cancer Center
Sean Hanlon, Ph.D., NIH/NCI
Lyndsay Harris, M.D., NIH/NCI
Steffan Ho, M.D., Ph.D., Pfizer
Karl Hsu, M.D., Sanofi
Mohamad Hussein, M.D., Celgene Corporation
Peter Intile, Society for Immunotherapy of Cancer
John Jessup, M.D.
Natalie LaFranzo, Ph.D., Cofactor Genomics
Rachel Lieberman, Society for Immunotherapy of Cancer
Tracy Lively, Ph.D., NIH/NCI
Ilan (Lanny) Kirsch, M.D., Adaptive Biotechnologies
Heather Manza, M.S., BioIVT
Daniel Maslyar, Alector
Ian McCaffery, Ph.D., Janssen
Robert McCormack, Ph.D.
Helen Moore, Ph.D., NIH/NCI
Larry Nagahara, Ph.D., Johns Hopkins University
Michael O’Neal, M.D., BioClinica, Inc.
Snehal Patel, Ph.D., Association for Molecular Oncology
Narges Rashidi, Ph.D., Olink Proteomics
Gregory Reaman, M.D., FDA/CDER
Josina Reddy, M.D., Genentech, a member of the Roche Group
Ximena Restrepo, M.S., CPHP, Society for Immunotherapy of Cancer
Henry Rodriguez, Ph.D., NIH/NCI
Marijana Rucevic, Ph.D., Olink Proteomics
Amy Kate Sasser, Ph.D., Genmab
Houssein Abdul Sater, M.D., NIH/NCI
Andrew E. Schade, M.D., Ph.D., Eli Lilly & Company
Julie Schneider, Ph.D., FDA/OC
Lawrence Schwartz, M.D., Columbia University
Maggie Scully, Ph.D., Frederick National Laboratory For Cancer Research
Ellen V. Sigal, Ph.D., Friends of Cancer Research
Andrew D. Simmons, Ph.D., Clovis Oncology
Daniel C. Sullivan, M.D., Duke University
Magdalena Thurin, Ph.D., NIH/NCI
Mickey Williams, Ph.D., NIH/NCI
Kevin Yarasheski, Ph.D., C2N Diagnositcs

  Inflammation & Immunity Steering Committee

David Fox, M.D., University of Michigan (Co-Chair)
Industry Co-Chair - Vacant
Tony Aliprantis, M.D., Ph.D., Merck
Fred Baribaud, Ph.D., Janssen 
Robert Benschop, Ph.D., Eli Lilly
Maria Bettinotti, Ph.D., Association for Molecular Pathology
Anita Boyapati, Ph.D., Regeneron
Katherine Call, Ph.D., Genzyme (Sanofi)
Claudio Carini, M.D., Ph.D., Oxford Biodynamics
James Chung, M.D., Amgen
Carolyn Cuff, Ph.D., AbbVie
Mark Curran, Ph.D., Janssen 
Sean Curtis, M.D., Merck
Sahar Dawisha, M.D., FDA/CDRH
Betty Diamond, Ph.D., Feinstein Institute
Guy Eakin, Ph.D., Arthritis Foundation
Thomas Fuerst, Ph.D., BioClinica
Janet Griffiths, Ph.D., AstraZeneca
Heath Guay, Ph.D., AbbVie
Jennifer Hall, Ph.D., American Heart Association
Caren Heller, M.D., MBA, Crohn's & Colitis Foundation of America
Marty Hodge, Ph.D., Pfizer
Kathy Jung, Ph.D.,  NIH/NIAA
Kirstie Keller, Ph.D., Milken Institute Center for Strategic Philanthropy
Natalie LaFranzo, Ph.D., Cofactor Genomics
Wini Luty, M.S., BioIVT
Daniel Maslyar, M.D., Alector
Bruce McManus, M.D., Ph.D., University of British Columbia
Nikolay Nikolov, M.D., FDA/CDER
Barbara Radziszewska, Ph.D., M.P.H., NIH/NIA
Narges Rashidi, Ph.D., OLINK
John Reveille, M.D., University of Texas Health Science Center (Houston)
Lisa Rider, M.D., NIH/NIEHS
Dan Rotrosen, M.D., NIH/NIAID
Jane Salmon, M.D., Hospital for Special Surgery
Maggie Scully, Ph.D., Frederick National Lab for Cancer Research
Susana A. Serrate-Sztein, M.D., NIH/NIAMS
Glennda Smithson, Ph.D., Takeda
Lisa M. Spain, Ph.D., NIH/ NIDDK
Giorgio Trinchieri, M.D., NIH/NCI
Ursula Utz, MBA, Ph.D., NIH/ NINDS
James Witter, M.D., Ph.D., NIH/NIAMS
Kevin Yarasheski, Ph.D., C2N Diagnostics

  Metabolic Disorders Steering Committee

Saul Malozowski, M.D., Ph.D., M.B.A. NIH/NIDDK (Co-Chair)
Roberto Calle, M.D., Pfizer (Co-Chair)
Poulabi Banerjee, Ph.D., Regeneron
Carlos Blanco, M.D., Ph.D., NIH/NIDA
Anita Boyapati, Ph.D., Regeneron
Kenneth Brouwer, Ph.D., R.Ph., BioIVT
Bidisha Dasgupta, Ph.D., JNJ
Christophe Depre, M.D., Eli Lilly
Samuel Engel, M.D., Merck
Klaus Engelke, Ph.D., BioClinica
David Fryburg, M.D., ROI BioPharma Consulting
Saurabh Gupta, Ph.D., Takeda
Jennifer Hall, M.D., The American Heart Association
Aaron Hinken, Ph,.D., GSK
Boaz Hirschberg, M.D., AstraZeneca
Claude Hughes, M.D., Ph.D., Quintiles
Scott Jacober, Ph.D., Sanofi
Teresa L. Jones, M.D., NIH/ NIDDK
Lyndon Joseph, Ph.D., NIH/NIA
Helina Kassahun, M.D., Amgen
Keith Kaufman, M.D., Merck
Young S. Kim, Ph.D., NIH/NCI
Paul Kimmel, M.D., NIH/NIDDK
Olof Dahlqvist Leinhard, Ph.D., AMRA Medical
Saul Malozowski, M.D., Ph.D., MBA, NIH/NIDDK
Rong Mao, M.D., The Association for Molecular Pathology
Frank Martin, Ph.D., JDRF
Allison McElvaine, Ph.D., ADA
Bruce Mitlak, M.D., Radius Health
Linda Morrow, M.D., ProSciento, Inc.
David Neil, M.D., GSK
John W. Newcomer, M.D., Florida Atlantic University
Maria-Magdalena Petru, M.D., Ortho Clinical Diagnostics
Afshin Parsa, M.D., MPH, NIH/NIDDK
Vandana Sachdev, M.D., NIH/NHLBI
Arun Sanyal, M.D., VCU
Bruce S. Schneider, M.D., FDA/CBER
Sudha Shankar, M.D., NGM Bio
Pothur Srinivas, Ph.D., NIH/NHLBI
Elizabeth Stafford, Ph.D., FDA/CDRH
Moises Torres-Gonzalez, Ph.D., National Dairy Council
Robert Umek, Ph. D., MesoScale Diagnostics
David R. Vera, Ph.D., University of California, San Diego
Michael Weisman, M.D., Cedars Sinai
Kevin Yarasheski, Ph.D., C2N Diagnostics

  Neuroscience Steering Committee

Linda Brady, Ph.D., NIH/NIMH (Co-Chair)
Hartmuth Kolb, Ph.D., J&J (Co-Chair)
William Potter, M.D., Ph.D., NIH/NIMH (Co-Chair Emeritus)
Daniel Barboriak, M.D., RSNA
Wade Berrettini, M.D., Ph.D., UPenn
Nicole Bjorklund, Ph.D., ADDF
Brian Campbell, Ph.D., Ryan Institute Neuroscience
Claudio Carini, M.D. Ph.D., Oxford Biodynamics
Maria Carrillo, Ph.D., Alzheimer's Association
Caroline Cohen, Ph.D., Sanofi
Susan Croll, Ph.D., Regeneron
Richard Dolmetsch, Ph.D., Novartis
Rbecca Edelmayer, Ph.D., Alzheimer's Association
Ahmed Enayetalla, Ph.D., Amgen
Howard Fillit, M.D., ADDF
Thomas P. Finn, Ph.D., FDA/CBER
Bernard Fischer, M.D., FDA/CDER
Mark Frasier, Ph.D., Michael J. Fox Foundation
Danielle Graham, Ph.D., Biogen Idec
Jon Heimer, Olink Proteomics
M. Katherine Jung, Ph.D., NIH/NIAAA
Johanne Kaplan, Ph.D., ProMIS Neurosciences; Pharma GmbH
Walter J. Koroshetz, M.D., NIH/NINDS
Frank Lebeda, Ph.D., US Military
Eliezer Masliah, Ph.D., NIH/NIA
Bradley Miller, M.D., Ph.D., Lilly
Cathie Miller, Ph.D., BioIVT
David Millis, M.D., M.B.A., Ph.D., FDA/CDER
Jose Luis Molinuevo, M.D., Ph.D., Barcelona Beta Brain Research Center
Niels Plath, Ph.D., Lundbeck
Josh Porter, OLink Proteomics
Kurt Rasmussen, Ph.D., NIH/NIDA
Sounder Regunathan, Ph.D., NIH/NIAAA
Ronenn Roubenoff, M.D., Novartis
Cristina Sampaio, M.D., Ph.D., CHDI
Steve Sands, Ph.D., Amgen
Darryl Schoepp, Ph.D., Merck & Co.
Nina Schor, Ph.D., NIH/NINDS
Howard Schulman, Ph.D., Allosteros Therapeutics
Lamya Shihabuddin, Ph.D., Sanofi
Holly Soares, Ph.D., Abbvie
Joyce Suhy, Ph.D., BioClinica
Nadine Tatton, Ph.D., AFTD
Johannes Tauscher, M.D., Takeda
Chris Turck, Ph.D., Max Planck Institute of Psychiatry
Robert Umek, Ph.D. Meso-Scale Diagnostics
Kevin Yarasheski, Ph.D., C2N Diagnositcs
Henrik Zetterberg, M.D., Ph.D., University of Gothenburg
 

 

Front Page: